Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Biotechnology  >  Genetics & Genomics

Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine


Published Date: April 2009
Published By: Decision Resources
Page Count: 29
Order Code: R55-638
 
DescriptionTable of ContentsSimilar
Products

Introduction

One of the fastest-growing segments of molecular diagnostics is nucleic acid testing (NAT). NAT is central to the life sciences industry, to improved healthcare, and to personalized medicine. Tools based on NAT are used to discover new biomarkers and develop in vitro diagnostics. Companies large and small are recognizing the value of NAT, and both R&D and dealmaking activity is robust. Find out who the players are and how they are vying for commercial success.

Get the Answers You Need to Shape Your Strategy
  • NAT is a leading molecular diagnostics technology. What are the advantages of NAT over other molecular diagnostics technologies? Which elements of NAT will drive personalized medicine forward?
  • Polymerase chain reaction (PCR) is one of the most common methods in the NAT toolbox used to discover new biomarkers and develop diagnostics tests. What other methods are commonly used for NAT? Which of these methods have the most product development activity?
  • Roche Diagnostics is the clear leader in molecular diagnostics. How do Roche’s sales fi gures compare with those of smaller diagnostics players? What does the competition look like within the smaller segments? How are companies using dealmaking to advance their positions?
  • Infectious disease and oncology are the two main therapy areas for use of NAT technologies. What are the growth trends and growth drivers within these therapy areas? What companies are positioned to tap the opportunities?
Scope
  • Importance of NAT for advancing personalized medicine: Use of and rationale for NAT techniques and products to support the push for personalized medicine.
  • Key mergers and acquisitions (M&As), collaboration, and licensing activities in NAT: Two tables featuring 92 alliances that occurred from November 2007 through December 2008.
  • Leading NAT markets: Types of assays and tests within infectious disease and oncology that will continue to have a strong presence in the NAT market.
  • Future trends: Insight into strategic considerations required to drive the NAT market and NAT companies forward.

Similar Products
Biotechnology Sector
Published Nov 2009 by First Research, Inc.


Dealmaking and Industry Outlook: Neurological Disease
Published Nov 2009 by Decision Resources


Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB


Plunkett's Health Care Technologies Overview 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.


The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management
Published Oct 2009 by IDC


Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018
Published Oct 2009 by Venture Planning Group


Preventive Healthcare Technologies, Products and Markets
Published Oct 2009 by BCC Research


Transfection Life Science Dashboard™ Series 2
Published Oct 2009 by Percepta Associates, Inc.


Genealogy Products and Services
Published Oct 2009 by Global Industry Analysts


Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Published Oct 2009 by Business Insights




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com